Evidence map›Paper›PMID 21720087›Full record

ReviewJournal of Nippon Medical School = Nippon Ika Daigaku zasshi2011

Development and maintenance of cancer stem cells under chronic inflammation.

Toshihiko Tanno, William Matsui

Abstract readReview
In one paragraph

Review in Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Cytokine-producing function of human blood cells in chronic atrophic gastritis and gastric adenomas and adenocarcinomas.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Toshihiko TannoJohns Hopkins University School of Medicine, Department of Oncology/Hematologic Malignancies, USA. ttannol@jhmi.edu
William Matsui

Funding

Cellular diversity and clinical relevance of stem cells in pancreatic cancerR01CA150142 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATSUI, WILLIAM H · 2011 to 2015
$1.7M
Cancer Stem Cell Targeting in Multiple MyelomaR01CA127574 · NCI · JOHNS HOPKINS UNIVERSITY · PI MATSUI, WILLIAM H · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA127574NCI NIH HHS R01 CA150142
6 · The paper itself

Abstract

In many human cancers, tumorigenic potential is not equally shared by all cells but is restricted to phenotypically distinct subpopulations termed cancer stem cells. Cancer stem cells are also capable of both self-renewal and differentiation, and these functional properties have been suggested to play major roles in tumor initiation and progression. The factors responsible for the development of cancer stem cells and their subsequent regulation are unclear, but several chronic inflammatory states have been associated with an increased risk of malignancy. Therefore, it is possible that specific processes associated with chronic inflammation, as well as the adaptation to cellular stress, regulate cancer stem cells. Several factors associated with chronic inflammation, including cytokines, oxidative stress, and hypoxia, induce the activation of specific cellular response programs that can affect the survival, proliferation, metabolism, and differentiation of cancer cells, as well as the self-renewal and quiescence of normal stem cells. In this review, we discuss how these adaptive processes potentially become subverted to enhance the development and function of cancer stem cells.

Indexed as

Chronic DiseaseHumansInflammationNeoplastic Stem CellsOxidative StressRegenerationWound Healing

Identifiers

PMID21720087
PMCPMC3380605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.